Mohtashami Nanaz 4

What Happened Nanaz Mohtashami, a director of Hologic, Inc. (HOLX), received a grant of 3,190 restricted stock units (RSUs) on February 26, 2026. The filing reports an award (transaction code A); no per-share price or immediate cash value is provided because these are RSUs rather than a market purchase or sale.

Key Details

• Transaction date: 2026-02-26 (Form 4 filed 2026-03-02).
• Grant amount: 3,190 RSUs; price reported as N/A (RSUs, not an open-market trade).
• Vesting/settlement: Footnote states RSUs vest on the date of the 2027 Annual Meeting and are settled one-for-one in shares of common stock (F1, F2).
• Shares owned after transaction: not specified in the filing.
• Timeliness: The Form 4 was filed four days after the grant; Form 4s are typically due within two business days, so this filing appears to have been submitted late.

Context RSU grants to directors are a common form of compensation and are not the same as a purchase or sale of stock; they only convert into shares if/when they vest and are settled. This award does not indicate an immediate market transaction or sale and should be viewed as compensation rather than an explicit bullish or bearish trading signal.